Breast Cancer
ERBB2 variant Ile654Val associated with increased familial breast cancer risk
Published in Women's Health Weekly, June 2nd, 2005
According to published research from Germany, "Overexpression of the proto-oncogene ERBB2 (HER2/NEU) has been observed in 20-30% of breast cancers involving poor prognosis. Genetic alterations within ERBB2 have been shown to induce carcinogenesis and metastasis.
"We investigated eight annotated single nucleotide polymorphisms for occurrence in familial breast cancer samples. The confirmed variants Ile654Val, Ile655Val and Ala1170Pro were analyzed in subsequent epidemiological studies on familial breast cancer risk."
"While Ala1170Pro resides...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Alcohol Use
Acute imbibing disrupts hormonal milieu of lactating women, reduces milk supply - Breast Cancer
Study findings suggest cancer etiology and outcome may be linked - Breast Cancer
Substantial 15-year survival gains from standard treatments - Ovarian Cancer
Blood test may detect deadly cancer in its early stages - Acute Liver Failure
HLA homozygosity confers susceptibility to non-A non-B hepatitis - Addiction Medicine
Community-based intervention effective for homeless, cocaine-using, black women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
